This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bend Research, Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of John E. Byers
Introduction
John E. Byers is a notable inventor based in Bend, Oregon. He has made significant contributions to the field of pharmaceuticals, particularly in the development of immediate release dosage forms. His work has led to advancements that enhance the effectiveness of drug delivery systems.
Latest Patents
John E. Byers holds a patent for "Immediate release dosage forms containing solid drug dispersions." This innovative patent describes high loading immediate release dosage forms that contain at least 30 wt % of a solid drug dispersion, at least 5 wt % of a disintegrant, and a porosigen. These formulations exhibit excellent strength and aqueous solubility, making them valuable in the pharmaceutical industry. He has 1 patent to his name.
Career Highlights
Throughout his career, John has worked with Bend Research, Inc., where he has been instrumental in developing new drug formulations. His expertise in solid drug dispersions has positioned him as a key figure in the research and development of effective pharmaceutical products.
Collaborations
John E. Byers has collaborated with talented individuals such as Leah Elizabeth Appel and Marshall David Crew. These partnerships have fostered innovation and contributed to the success of various projects within the company.
Conclusion
John E. Byers is a distinguished inventor whose work in immediate release dosage forms has made a significant impact on the pharmaceutical industry. His contributions continue to influence drug delivery systems, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
